This inventor holds 1 USPTO granted patent. Top assignee: Huahui Health Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Huisi Liu - Innovator in Antibody Development
Introduction
Huisi Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on addressing diseases related to abnormal signaling pathways.
Latest Patents
Huisi Liu holds a patent for "Anti-FGF19 antibodies." This patent provides anti-FGF19 antibodies that selectively target the N-terminus of fibroblast growth factor 19 (FGF19) and antigen-binding fragments thereof. These antibodies have potential applications in treating diseases or disorders caused by abnormal FGF19-FGFR4 signaling, such as cancer.
Career Highlights
Liu is associated with Huahui Health Ltd., where he continues to advance his research and development efforts. His innovative work in antibody technology has positioned him as a key figure in the biotechnology sector.
Collaborations
One of his notable collaborators is Jianhua Sui, with whom he has worked on various projects related to antibody development.
Conclusion
Huisi Liu's contributions to the field of biotechnology, particularly through his patent on anti-FGF19 antibodies, highlight his role as an innovator in therapeutic solutions. His ongoing work at Huahui Health Ltd. continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile